Swetha Ramadesikan

659 total citations · 1 hit paper
16 papers, 405 citations indexed

About

Swetha Ramadesikan is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Swetha Ramadesikan has authored 16 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Swetha Ramadesikan's work include Cellular transport and secretion (4 papers), Genomics and Rare Diseases (3 papers) and Renal and related cancers (3 papers). Swetha Ramadesikan is often cited by papers focused on Cellular transport and secretion (4 papers), Genomics and Rare Diseases (3 papers) and Renal and related cancers (3 papers). Swetha Ramadesikan collaborates with scholars based in United States, United Kingdom and France. Swetha Ramadesikan's co-authors include Joseph V. Bonventre, Venkata Sabbisetti, Mark Radlinski, Daniel J. Antoine, Sahil Sharma, James W. Dear, Sushrut S. Waikar, Philip L. De Jager, Adam M. Smiles and Rebeccah Briskin and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of the American Society of Nephrology.

In The Last Decade

Swetha Ramadesikan

11 papers receiving 399 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes

2014 327 citations Venkata Sabbisetti, Sushrut S. Waikar et al. Journal of the American Society of Nephrology profile →

Peers

Countries citing papers authored by Swetha Ramadesikan

Since Specialization

Citations

This map shows the geographic impact of Swetha Ramadesikan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swetha Ramadesikan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swetha Ramadesikan more than expected).

Fields of papers citing papers by Swetha Ramadesikan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swetha Ramadesikan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swetha Ramadesikan. The network helps show where Swetha Ramadesikan may publish in the future.

Co-authorship network of co-authors of Swetha Ramadesikan

This figure shows the co-authorship network connecting the top 25 collaborators of Swetha Ramadesikan. A scholar is included among the top collaborators of Swetha Ramadesikan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swetha Ramadesikan. Swetha Ramadesikan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Three Siblings With an Attenuated Presentation of Perlman Syndrome: A Case Report and Literature Review 2025 ·Molecular Genetics & Genomic Medicine ·(unknown), Daniel C. Koboldt, Swetha Ramadesikan, (unknown), (unknown), Anthony R. Miller, (unknown), C.Phil Comer, James I. Geller, (unknown), Nilay Shah, Marco L. Leung	0
2	Novel Intragenic Duplication of GATAD2B in a Patient With GAND 2025 ·American Journal of Medical Genetics Part A ·Mari Mori, Steven Estes, Swetha Ramadesikan, (unknown), (unknown), (unknown), Anthony R. Miller, Bimal P. Chaudhari, Richard K. Wilson, Daniel C. Koboldt	0
3	Expanding the phenotypic spectrum of CSNK2A1-associated Okur-Chung neurodevelopmental syndrome 2024 ·Human Genetics and Genomics Advances ·Swetha Ramadesikan, (unknown), (unknown), Allison C. Daley, Liz Varga, Gurusamy Umamaheswaran, Matthew Pastore, Emily Sites, (unknown), Dennis W. Bartholomew, Jesse M. Hunter, Peter D. White, Richard K. Wilson, Rolf W. Stottmann, Daniel C. Koboldt	1
4	Long-read genome sequencing resolves complex genomic rearrangements in rare genetic syndromes 2024 ·npj Genomic Medicine ·(unknown), (unknown), Swetha Ramadesikan, (unknown), Allison C. Daley, (unknown), Matthew Pastore, Gurusamy Umamaheswaran, Jesse M. Hunter, (unknown), Dennis W. Bartholomew, Kandamurugu Manickam, Anthony R. Miller, Richard K. Wilson, Rolf W. Stottmann, Daniel C. Koboldt	2
5	Biallelic variants in HTRA2 cause 3-methylglutaconic aciduria mitochondrial disorder: case report and literature review 2024 ·Frontiers in Genetics ·Gurusamy Umamaheswaran, Swetha Ramadesikan, (unknown), (unknown), Jesse M. Hunter, Marco L. Leung, Elaine R. Mardis, Peter White, (unknown), Richard K. Wilson, Daniel C. Koboldt	0
6	A novel IKZF1 variant in a family with autosomal dominant CVID: A case for expanding exon coverage in inborn errors of immunity 2024 ·Clinical Immunology ·(unknown), Benjamin T. Prince, Hye Sun Kuehn, (unknown), Liz Varga, Sergio D. Rosenzweig, Swetha Ramadesikan, (unknown), (unknown), Peter Chang, Elaine R. Mardis, Daniel C. Koboldt	0
7	LGG-14. TREATMENT OF TWO PEDIATRIC FGFR-ALTERED LOW-GRADE GLIONEURONAL TUMORS WITH MEK INHIBITION 2023 ·Neuro-Oncology ·Margot Lazow, Diana Thomas, Catherine E. Cottrell, (unknown), Swetha Ramadesikan, Ralph Salloum, Ammar Shaikhouni, Elaine R. Mardis, Jeremy Jones, Jeffrey R. Leonard, Daniel R. Boué, Maryam Fouladi, Kathleen M. Schieffer	3
8	Heterogeneity in Lowe Syndrome: Mutations Affecting the Phosphatase Domain of OCRL1 Differ in Impact on Enzymatic Activity and Severity of Cellular Phenotypes 2023 ·Biomolecules ·(unknown), Swetha Ramadesikan, (unknown), Charles Christoffer, (unknown), (unknown), (unknown), (unknown), Cynthia V. Stauffacher, Daisuke Kihara, R. Claudio Aguilar	5
9	The Future of Genetic Disease Studies: Assembling an Updated Multidisciplinary Toolbox 2022 ·Frontiers in Cell and Developmental Biology ·Swetha Ramadesikan, Jennifer Lee, R. Claudio Aguilar	0
10	Biallelic SEPSECS variants in two siblings with pontocerebellar hypoplasia type 2D underscore the relevance of splice-disrupting synonymous variants in disease. 2022 ·Molecular Case Studies ·Swetha Ramadesikan, Scott E. Hickey, Emily de los Reyes, Anup D. Patel, (unknown), Patrick J. Brennan, (unknown), Kristy Lee, Peter White, Kim L. McBride, Daniel C. Koboldt, Richard K. Wilson	1
11	Genotype & phenotype in Lowe Syndrome: specific OCRL1 patient mutations differentially impact cellular phenotypes 2021 ·Human Molecular Genetics ·Swetha Ramadesikan, (unknown), Jennifer Lee, Kayalvizhi Madhivanan, Daipayan Sarkar, (unknown), (unknown), Genki Terashi, Tony R. Hazbun, Daisuke Kihara, R. Claudio Aguilar	13
12	Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins 2020 ·Human Molecular Genetics ·Kayalvizhi Madhivanan, Swetha Ramadesikan, (unknown), (unknown), (unknown), Robert L. Bacallao, R. Claudio Aguilar	11
13	Kidney-differentiated cells derived from Lowe Syndrome patient’s iPSCs show ciliogenesis defects and Six2 retention at the Golgi complex 2018 ·PLoS ONE ·(unknown), Swetha Ramadesikan, Donna M. Fekete, R. Claudio Aguilar	11
14	Role of Ocrl1 in Primary Cilia Assembly 2015 ·International review of cell and molecular biology ·Kayalvizhi Madhivanan, Swetha Ramadesikan, R. Claudio Aguilar	13
15	Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes breakdown → 2014 ·Journal of the American Society of Nephrology ·Venkata Sabbisetti, Sushrut S. Waikar, Daniel J. Antoine, Adam M. Smiles, Chang Wang, (unknown), Kazumi Ito, Sahil Sharma, Swetha Ramadesikan, Michelle Lee, Rebeccah Briskin, Philip L. De Jager, (unknown), Mark Radlinski, James W. Dear, Kevin B. Park, Rebecca A. Betensky, Andrzej S. Królewski, Joseph V. Bonventre	327
16	Abstract 5195: Kidney injury molecule-1: a novel therapeutic target in renal cell carcinoma. 2013 ·Cancer Research ·Venkata Sabbisetti, Rupal S. Bhatt, Swetha Ramadesikan, Joseph V. Bonventre	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact